Rodman & Renshaw Reiterates Market Underperform and PT of $13 on Medivation

Rodman & Renshaw reiterated its Market Underperform on Medivation (NASDAQ: MDVN). At the same time, the rating agency left its price target on the company's stock unchanged at $13. On Wednesday, MDVN lost 11.37% of its value to end the day at $15.36.